Profile data is unavailable for this security.
About the company
Patrys Limited is an Australia-based company, which is focused on the development of its deoxymab platform of cell-penetrating antibodies as therapies for a range of different cancers. The Company's deoxymab platform is based on the deoxymab 3E10 antibody that was identified as an autoantibody in a mouse model of the human disease systemic lupus erythematosus. It has developed two humanized forms of deoxymab 3E10, both of which have improved activity over the original deoxymab 3E10 antibody: PAT-DX1, which is a dimer (two joined subunits) of the short chain from the binding domain of deoxymab 3E10, and PAT-DX3, which is a full-sized Immunoglobulin G antibody. Deoxymabs, such as PAT-DX1 and PAT-DX3, can be used to target nanoparticles carrying a payload of anti-cancer drugs specifically to tumors. Its PAT-DX1- nanoparticles (NP) pipeline involves using its PAT-DX1 to develop a new drug based on the targeted delivery of NP carrying therapeutic payloads to the inside of cancer cells.
- Revenue in AUD (TTM)1.70m
- Net income in AUD-5.12m
- Incorporated2006
- Employees15.00
- LocationPatrys LtdLevel 4, 96-100 Albert RoadSOUTH MELBOURNE 3205AustraliaAUS
- Phone+61 39670-3273
- Fax+61 39670-3247
- Websitehttps://patrys.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nyrada Inc | 3.08m | -4.98m | 11.66m | -- | -- | 2.21 | -- | 3.79 | -0.0319 | -0.0319 | 0.0198 | 0.0294 | 0.3983 | -- | -- | -- | -64.37 | -64.90 | -71.93 | -84.66 | -- | -- | -161.62 | -380.62 | -- | -15,086.39 | 0.00 | -- | 42.54 | 229.09 | -96.52 | -- | -- | -- |
Tissue Repair Ltd | 457.52k | -3.28m | 12.28m | -- | -- | 0.7724 | -- | 26.84 | -0.0542 | -0.0542 | 0.0076 | 0.2848 | 0.0209 | -- | 7.95 | -- | -14.96 | -- | -15.46 | -- | 98.19 | -- | -716.30 | -- | 25.84 | -- | 0.00 | -- | -- | -- | 38.95 | -- | -- | -- |
Bioxyne Ltd | 8.65m | -14.17m | 12.28m | 16.00 | -- | 3.94 | -- | 1.42 | -0.0074 | -0.0074 | 0.0044 | 0.0015 | 1.83 | 6.12 | 10.50 | -- | -302.23 | -22.07 | -418.10 | -28.50 | 38.30 | 45.13 | -165.04 | -39.69 | 1.50 | -- | 0.00 | -- | 1,013.05 | 20.97 | -292.69 | -- | -19.86 | -- |
Adalta Ltd | 3.56m | -5.04m | 12.80m | -- | -- | 5.21 | -- | 3.59 | -0.0129 | -0.0129 | 0.0092 | 0.0046 | 0.5491 | -- | 4.72 | -- | -77.76 | -67.77 | -195.09 | -103.16 | -- | -- | -141.60 | -160.72 | -- | -57.86 | 0.4533 | -- | 28.18 | 11.17 | 19.96 | -- | -7.47 | -- |
BTC Health Ltd | 16.03k | -8.26m | 14.59m | 1.00 | -- | 2.69 | 8.84 | 909.89 | -0.0305 | -0.0305 | 0.00005 | 0.0167 | 0.0017 | -- | 0.031 | -- | -89.67 | -23.15 | -91.36 | -24.64 | -- | -- | -51,522.02 | -2,498.18 | -- | -0.0787 | 0.00 | -- | -86.04 | -26.76 | -1,665.01 | -- | -- | -- |
Medlab Clinical Ltd | 943.67k | -6.78m | 15.07m | 14.00 | -- | -- | -- | 15.97 | -2.97 | -2.97 | 0.4133 | 0.5604 | 0.1301 | 2.25 | 10.35 | -- | -88.67 | -55.07 | -127.20 | -69.75 | 90.45 | 52.86 | -681.73 | -335.43 | 1.67 | -217.55 | 0.00 | -- | -28.90 | -29.83 | 18.55 | -- | -30.00 | -- |
Patrys Ltd | 1.70m | -5.12m | 15.43m | 15.00 | -- | 3.07 | -- | 9.10 | -0.0025 | -0.0025 | 0.0008 | 0.0024 | 0.1978 | -- | 0.5828 | -- | -59.77 | -43.96 | -68.99 | -47.06 | -- | -- | -302.26 | -230.44 | -- | -- | 0.00 | -- | -14.45 | 40.52 | -4.15 | -- | -- | -- |
Amplia Therapeutics Ltd | 1.87m | -4.46m | 15.75m | 1.00 | -- | 0.7848 | -- | 8.43 | -0.0224 | -0.0224 | 0.0094 | 0.0739 | 0.0949 | -- | 0.7018 | -- | -22.64 | -25.27 | -26.24 | -26.78 | -- | -- | -238.69 | -342.26 | -- | -- | 0.1318 | -- | -42.10 | 12.31 | -71.30 | -- | 31.88 | -- |
Argent BioPharma Ltd | 1.32m | -17.02m | 16.07m | -- | -- | 9.55 | -- | 12.14 | -3.32 | -3.32 | 0.1003 | 0.0372 | 0.0813 | 0.7078 | 1.58 | -- | -105.32 | -111.29 | -345.98 | -171.05 | 21.87 | 32.52 | -1,295.20 | -632.42 | 0.6561 | -24.85 | 0.4104 | -- | -28.41 | 47.31 | -2.34 | -- | -16.20 | -- |
Radiopharm Theranostics Ltd | 0.00 | -46.82m | 16.26m | -- | -- | 0.5521 | -- | -- | -0.1343 | -0.1343 | 0.00 | 0.0652 | 0.00 | -- | -- | -- | -63.11 | -- | -77.85 | -- | -- | -- | -- | -- | -- | -7.48 | 0.00 | -- | -- | -- | -13.78 | -- | -- | -- |
Oncosil Medical Ltd | 355.30k | -11.71m | 16.59m | 2.00 | -- | 2.56 | -- | 46.68 | -0.0081 | -0.0081 | 0.0002 | 0.002 | 0.0506 | -- | 7.88 | -- | -166.55 | -57.65 | -234.81 | -64.83 | -426.96 | -- | -3,295.08 | -473.02 | -- | -68.93 | 0.0256 | -- | -59.92 | -37.72 | -5.74 | -- | 40.13 | -- |
Auscann Group Holdings Ltd | 2.05m | -9.44m | 17.64m | 27.00 | -- | -- | -- | 8.61 | -0.0213 | -0.0217 | 0.0043 | 0.0162 | 0.1674 | -- | 5.35 | -- | -77.15 | -39.85 | -78.72 | -40.73 | 100.59 | -- | -460.74 | -925.91 | -- | -23.16 | 0.00 | -- | 13.88 | 51.37 | 57.10 | -- | -- | -- |
Chimeric Therapeutics Ltd | 0.00 | -11.31m | 17.98m | -- | -- | 1.10 | -- | -- | -0.027 | -0.027 | 0.00 | 0.0191 | 0.00 | -- | -- | -- | -45.96 | -- | -69.36 | -- | -- | -- | -- | -- | -- | -10.01 | 0.1596 | -- | -- | -- | -60.40 | -- | -- | -- |
Acrux Ltd | 14.46m | -709.00k | 18.32m | 43.00 | -- | 3.24 | -- | 1.27 | -0.0024 | -0.0024 | 0.0502 | 0.0195 | 1.29 | -- | 4.86 | -- | -6.34 | -39.91 | -9.21 | -46.00 | 72.38 | -- | -4.90 | -132.53 | -- | -- | 0.2861 | -- | 133.74 | 28.29 | 92.23 | -- | -16.66 | -- |
Algorae Pharmaceuticals Ltd | 84.10k | -2.25m | 18.56m | -- | -- | 5.12 | -- | 220.70 | -0.0015 | -0.0015 | 0.00006 | 0.0022 | 0.0245 | -- | 1.79 | -- | -65.51 | -46.12 | -70.91 | -53.52 | -- | -- | -2,678.04 | -591.05 | -- | -136.75 | 0.00 | -- | 1,132.26 | -44.06 | -7.68 | -- | -- | -- |
Rhythm Biosciences Ltd | 157.67k | -8.63m | 19.39m | -- | -- | 14.17 | -- | 122.98 | -0.0386 | -0.0386 | 0.0007 | 0.0055 | 0.0263 | -- | 1.81 | -- | -144.00 | -106.11 | -169.71 | -125.51 | -1,899.74 | -1,210.71 | -5,473.20 | -6,642.26 | 2.04 | -- | 0.0304 | -- | 814.18 | 28.77 | 6.55 | -- | -20.43 | -- |